Emergency hospitalizations for unsupervised prescription medication ingestions by young children - PubMed (original) (raw)
Multicenter Study
. 2014 Oct;134(4):e1009-16.
doi: 10.1542/peds.2014-0840. Epub 2014 Sep 15.
Affiliations
- PMID: 25225137
- PMCID: PMC4651431
- DOI: 10.1542/peds.2014-0840
Multicenter Study
Emergency hospitalizations for unsupervised prescription medication ingestions by young children
Maribeth C Lovegrove et al. Pediatrics. 2014 Oct.
Abstract
Background: Emergency department visits and subsequent hospitalizations of young children after unsupervised ingestions of prescription medications are increasing despite widespread use of child-resistant packaging and caregiver education efforts. Data on the medications implicated in ingestions are limited but could help identify prevention priorities and intervention strategies.
Methods: We used nationally representative adverse drug event data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project and national retail pharmacy prescription data from IMS Health to estimate the frequency and rates of emergency hospitalizations for unsupervised prescription medication ingestions by young children (2007-2011).
Results: On the basis of 1513 surveillance cases, 9490 estimated emergency hospitalizations (95% confidence interval: 6420-12,560) occurred annually in the United States for unsupervised prescription medication ingestions among children aged <6 years from 2007 through 2011; 75.4% involved 1- or 2-year old children. Opioids (17.6%) and benzodiazepines (10.1%) were the most commonly implicated medication classes. The most commonly implicated active ingredients were buprenorphine (7.7%) and clonidine (7.4%). The top 12 active ingredients, alone or in combination with others, were implicated in nearly half (45.0%) of hospitalizations. Accounting for the number of unique patients who received dispensed prescriptions, the hospitalization rate for unsupervised ingestion of buprenorphine products was significantly higher than rates for all other commonly implicated medications and 97-fold higher than the rate for oxycodone products (200.1 vs 2.1 hospitalizations per 100,000 unique patients).
Conclusions: Focusing unsupervised ingestion prevention efforts on medications with the highest hospitalization rates may efficiently achieve large public health impact.
Keywords: buprenorphine; drug packaging; opioids; pediatric hospitalization; poisoning; prescription drugs; sulfonylureas; unintentional overdose.
Copyright © 2014 by the American Academy of Pediatrics.
Conflict of interest statement
Potential Conflict of Interest disclosures: The authors have no conflicts of interest relevant to this article to disclose.
Figures
Figure 1. Estimated Rates of Emergency Hospitalizations for Unsupervised Oral Prescription Medication Ingestions by Children < 6 Years, United States, 2007–2011
Estimates of emergency hospitalizations for unsupervised oral prescription medication ingestions based on the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project, 2007–2011. Estimates of numbers of dispensed outpatient prescriptions and numbers of unique patients receiving dispensed prescriptions based on data from IMS Health, Vector One®, extracted August and September, 2013, respectively. aCoefficient of variation greater than 30%. bExcludes antitussive combination products.
Similar articles
- Ingestion of Over-the-Counter Liquid Medications: Emergency Department Visits by Children Aged Less Than 6 Years, 2012-2015.
Lovegrove MC, Weidle NJ, Budnitz DS. Lovegrove MC, et al. Am J Prev Med. 2019 Feb;56(2):288-292. doi: 10.1016/j.amepre.2018.10.004. Epub 2018 Dec 17. Am J Prev Med. 2019. PMID: 30573336 Free PMC article. - Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures.
Lovegrove MC, Weidle NJ, Geller AI, Lind JN, Rose KO, Goring SK, Budnitz DS. Lovegrove MC, et al. Am J Prev Med. 2023 Jun;64(6):834-843. doi: 10.1016/j.amepre.2023.01.011. Epub 2023 Apr 20. Am J Prev Med. 2023. PMID: 37210158 Free PMC article. - Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures, 2004-2013.
Lovegrove MC, Weidle NJ, Budnitz DS. Lovegrove MC, et al. Pediatrics. 2015 Oct;136(4):e821-9. doi: 10.1542/peds.2015-2092. Epub 2015 Sep 7. Pediatrics. 2015. PMID: 26347435 Free PMC article. - A 10-year review of single medication double-dose ingestions in the nation's largest poison control system.
Correia MS, Whitehead E, Cantrell FL, Lasoff DR, Minns AB. Correia MS, et al. Clin Toxicol (Phila). 2019 Jan;57(1):31-35. doi: 10.1080/15563650.2018.1493205. Epub 2018 Nov 28. Clin Toxicol (Phila). 2019. PMID: 30484705 Review. - Trends in Pediatric Recreational Drug Use and Ingestions.
Assaf RR, Young KD. Assaf RR, et al. Adv Pediatr. 2021 Aug;68:261-281. doi: 10.1016/j.yapd.2021.05.011. Epub 2021 Jun 17. Adv Pediatr. 2021. PMID: 34243857 Review. No abstract available.
Cited by
- Benzonatate Exposure Trends and Adverse Events.
Kim I, Goulding M, Tian F, Karami S, Pham T, Cheng C, Biehl A, Muñoz M. Kim I, et al. Pediatrics. 2022 Dec 1;150(6):e2022057779. doi: 10.1542/peds.2022-057779. Pediatrics. 2022. PMID: 36377394 Free PMC article. - Spatial, temporal, and space-time clusters associated with opioid and cannabis poisoning events in U.S. dogs (2005-2014).
Howard-Azzeh M, Pearl DL, Berke O, O'Sullivan TL. Howard-Azzeh M, et al. PLoS One. 2022 Apr 28;17(4):e0266883. doi: 10.1371/journal.pone.0266883. eCollection 2022. PLoS One. 2022. PMID: 35482776 Free PMC article. - A Standardized Cardiac Protocol for Pediatric Drug Ingestion Hospital Admissions.
Del Grippo EL, Baskar S, Gray S, Osakwe O, Powell AW, Anderson J, Spar D, Madsen N. Del Grippo EL, et al. Pediatr Qual Saf. 2019 Oct 23;4(6):e223. doi: 10.1097/pq9.0000000000000223. eCollection 2019 Nov-Dec. Pediatr Qual Saf. 2019. PMID: 32010850 Free PMC article. - The identification of risk factors contributing to accidental opioid poisonings in companion dogs using data from a North American poison control center (2006-2014).
Howard-Azzeh M, Pearl DL, O'Sullivan TL, Berke O. Howard-Azzeh M, et al. PLoS One. 2020 Jan 29;15(1):e0227701. doi: 10.1371/journal.pone.0227701. eCollection 2020. PLoS One. 2020. PMID: 31995582 Free PMC article. - The Role of Unit-Dose Child-Resistant Packaging in Unintentional Childhood Exposures to Buprenorphine-Naloxone Tablets.
Hampp C, Lovegrove MC, Budnitz DS, Mathew J, Ho A, McAninch J. Hampp C, et al. Drug Saf. 2020 Feb;43(2):189-191. doi: 10.1007/s40264-019-00883-6. Drug Saf. 2020. PMID: 31745829 Free PMC article. No abstract available.
References
- Rodgers GB. The safety effects of child-resistant packaging for oral prescription drugs: two decades of experience. JAMA. 1996;275(21):1661–1665. - PubMed
- US Consumer Product Safety Commission. Poison prevention packaging: a guide for healthcare professionals. Washington, DC: US Consumer Product Safety Commission; 2005.
- Budnitz DS, Salis S. Preventing medication overdoses in young children: an opportunity for harm elimination. Pediatrics. 2011;127(6):e1597–e1599. - PubMed
- Bronstein AC, Spyker DA, Cantilena LR, Jr, Rumack BH, Dart RC. 2011 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol (Phila) 2012;50(10):911–1164. - PubMed
- Bronstein AC, Spyker DA, Cantilena LR, Jr, Green JL, Rumack BH, Dart RC. 2010 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila) 2011;49(10):910–941. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical